Highlights from our recent 5th Annual Cross-project Meeting: partners celebrated first completed projects & reinforced the need for collaborative efforts in combating #AMR . Stay tuned for the final project updates from AB-Direct at ECCMID 2024 👀

amr-accelerator.eu/news/09-04-23-…

With #WorldTBDay coming up, we asked experts in the field to comment on the importance of investing in #TB R&D. Watch our video featuring Charles Wells of Bill & Melinda Gates Medical Research Institute, Cherise Scott of Unitaid & and Kelly Dooley of Vanderbilt Health 👉 youtu.be/CGFOv20zMns

📢 Upcoming UNITE4TB Webinar!

Topic: Community engagement in TB action
Date: Thursday, 28 March
Time: 13:00–14:00 CET
More info and link to register 👉 ersnet.org/events/panel-d…

#EndTB #Webinar #CommunityEngagement
Innovative Health Initiative IMI AMR ACCELERATOR ISPUP ERS European Lung Foundation

Thank you IMI AMR ACCELERATOR for bringing together our fellow AMR Accelerator partners to discuss our shared goal of progressing the development of new medicines to treat or prevent resistant bacterial infections 🙏 #Collaboration breeds success 💪 Innovative Health Initiative

If you're at the AMR Conference in Basel today, stop by the IMI AMR ACCELERATOR booth to grab a UNITE4TB brochure and learn more about our project and the other eight under the AMR Accelerator. #Collaboration #PublicPrivatePartnerships #GlobalHealth #EndTB Innovative Health Initiative

From input to impact 💪Yesterday, our project partner, David Barros-Aguirre from GSK, presented on UNITE4TB at the 5th IMI AMR ACCELERATOR Cross-Project Meeting in Basel. UNITE4TB is one of nine projects under the Accelerator. #PublicPrivatePartnerships #GlobalHealth #EndTB #AMR

🌟 2023 has been an eventful year for UNITE4TB, marked by the launch of our clinical trial program & other milestones. A big thank you to our partners & supporters for making it possible! Don't miss our latest Newsletter, recapping this year's highlights: rb.gy/8tvy4z

The UNITE4TB #clinicaltrial program aims to speed up the #drugdevelopment process & set a new standard in the way clinical studies are done. Dr. Wandini Lutchmun (@WLutchmun), Sponsor Medical Expert for the UNITE4TB DECISION study LMU Klinikum München, explains more 👇
Innovative Health Initiative

The UNITE4TB #clinicaltrials will test 14 combinations of nine existing drugs, as well as two newly developed candidates. Hear more from Dr. Ilaria Motta MRC Clinical Trials Unit at UCL @UCL, sponsor of the UNITE4TB PARADIGM4TB trial 👇Ilaria Motta Innovative Health Initiative IMI AMR ACCELERATOR #EndTB

Last month, we announced the start of our Phase 2B/C clinical trial program, which officially kicked off in Cape Town, South Africa. The South African trial site, part of the clinical research institute TASK, is one of several selected for the project. Hear from our consortium…

📢 Shape #tuberculosis (TB) research: Participate in our survey!
Purpose: To identify the most important outcomes for measurement in later-phase (phase 3) trials of pulmonary #TB
Who can participate:
• Those with experience of being treated for TB or who have cared for someone…

Included in our last newsletter ⬇️
💊1st Phase-2 clinical trials
🤝 global collaboration to improved in vivo #antibiotics testing
🛠️new resources to facilitate academia-industry collaboration in PPPs & provide clarity on the AMR burden in Europe
➕& more: sh1.sendinblue.com/ai2kcges1xpfe.…

During the #UnionConf2023 in Paris earlier this month, a meeting between the investigators of PARADIGM4TB took place. PARADIGM4TB, part of the UNITE4TB clinical trial program is sponsored by our consortium partner UCL. Find out more about the UNITE4TB clinical trial program 👉…

For people affected by #TB , the most important outcome of projects like UNITE4TB is rapid access to better regimens of shorter treatment duration & with fewer side effects, explains Phumeza Tisile 🏳️‍🌈, TB survivor & TBProof/GCTA Board Member 👇
#EndTB Innovative Health Initiative IMI AMR ACCELERATOR…

Two weeks ago, we announced a major milestone for our partnership and the #TB community as a whole, with the start of our Phase 2B/C clinical trial program.
Our Project Coordinator, Prof. Martin Boeree (Radboudumc) explains more 👇Radboudumc_weet Innovative Health Initiative IMI AMR ACCELERATOR

Last week, at the #UnionConf2023 , our joint session with PAN-TB provided a comprehensive overview of the ongoing efforts by both collaborations to radically innovate #TB #drugdevelopment . A summary of the session is now available on our website 👉 unite4tb.org/newsroom/unite…
#EndTB

📢 UNITE4TB #webinar
Topic: The importance of getting the dose right in anti-tuberculosis treatment
Date: 23 Nov, 13:00–14:00 CET
Speaker: Dr. Elin Svensson (Uppsala, Sweden)

More info & registration link 👉 ersnet.org/events/panel-d…

#EndTB #publicprivatepartnership Innovative Health Initiative…

Meaningful engagement of communities is crucial UNITE4TB The Union Conference Unitaid Unitaid_NGOs Stop TB Partnership Treatment Action Group (TAG)

“There’s no time like the present” - fantastic kickoff to our UNITE4TB and PAN-TB Collaboration session on how we are revolutionising #TB drug and regimen development Michael Hoelscher Hanif Esmail, Wandini Lutchmun Blessina Kumar

“If the communities are engaged and have better understanding from the start, there is better buy-in from the community. There is demand. There is ownership. Communities will ask for it.” - Blessina Kumar at UNITE4TB session at the The Union Conference